First Time Loading...
Have any thoughts about
Ilyang Pharmaceutical Co Ltd?
Write Note
I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 110 KRW -0.23%
Updated: Jun 12, 2024

Gross Margin
Ilyang Pharmaceutical Co Ltd

54.3%
Current
55%
Average
48.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.3%
=
Gross Profit
200.3B
/
Revenue
368.7B

Gross Margin Across Competitors

Country KR
Market Cap 235.6B KRW
Gross Margin
54%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 822.9B USD
Gross Margin
80%
Country DK
Market Cap 4.4T DKK
Gross Margin
85%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country US
Market Cap 353.2B USD
Gross Margin
70%
Country US
Market Cap 333.9B USD
Gross Margin
75%
Country UK
Market Cap 191.8B GBP
Gross Margin
82%
Country CH
Market Cap 192.6B CHF
Gross Margin
73%
Country CH
Market Cap 184.1B CHF
Gross Margin
74%
Country US
Market Cap 158.8B USD
Gross Margin
70%

Profitability Report

View the profitability report to see the full profitability analysis for Ilyang Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
54.3%
=
Gross Profit
200.3B
/
Revenue
368.7B
What is the Gross Margin of Ilyang Pharmaceutical Co Ltd?

Based on Ilyang Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 54.3%.